Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition[S]
Animal studies demonstrate that hyperlipidemia and renal lipid accumulation contribute to the pathogenesis of diabetic nephropathy (DN). We previously demonstrated that renal lipoproteins colocalize with biglycan, a renal proteoglycan. The purpose of this study was to determine whether prevention of...
Main Authors: | Patricia G. Wilson, Joel C. Thompson, Meghan H. Yoder, Richard Charnigo, Lisa R. Tannock |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520335537 |
Similar Items
-
A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[S]
by: Joel C. Thompson, et al.
Published: (2015-02-01) -
Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr−/− mice1
by: Tao Tang, et al.
Published: (2013-08-01) -
Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
by: John Aggelidakis, et al.
Published: (2018-10-01) -
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development1
by: Fei Huang, et al.
Published: (2008-03-01) -
Proteoglycan binding as proatherogenic function metric of apoB-containing lipoproteins and chronic kidney graft failure
by: Hannah L.M. Steffen, et al.
Published: (2021-01-01)